Claudia Manzl

About Claudia Manzl

Claudia Manzl, With an exceptional h-index of 29 and a recent h-index of 17 (since 2020), a distinguished researcher at Medizinische Universität Innsbruck, specializes in the field of Cell Biology, Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Influence of MMR, MGMT promotor methylation and protein expression on overall and progression-free survival in primary glioblastoma patients treated with temozolomide

Imaging Properties and Tumor Targeting of 68Ga-NeoBOMB1, a Gastrin-Releasing Peptide Receptor Antagonist, in GIST Patients

Molecular Characteristics of Radon Associated Lung Cancer Highlights MET Alterations

Nrf2 in the Field of Dentistry with Special Attention to NLRP3

Patients with double/triple copy number gains on C-MYC, BCL2, and/or BCL6 treated with standard chemotherapy have a similarly poor prognosis than those with high-grade B cell …

Development of bivalent triarylalkene-and cyclofenil-derived dual estrogen receptor antagonists and downregulators

Claudia Manzl Information

University

Position

Senior Scientist Department of Pathology

Citations(all)

2766

Citations(since 2020)

757

Cited By

2329

hIndex(all)

29

hIndex(since 2020)

17

i10Index(all)

43

i10Index(since 2020)

31

Email

University Profile Page

Google Scholar

Claudia Manzl Skills & Research Interests

Cell Biology

Oncology

Top articles of Claudia Manzl

Influence of MMR, MGMT promotor methylation and protein expression on overall and progression-free survival in primary glioblastoma patients treated with temozolomide

International Journal of Molecular Sciences

2023/3/24

Claudia Manzl
Claudia Manzl

H-Index: 19

Imaging Properties and Tumor Targeting of 68Ga-NeoBOMB1, a Gastrin-Releasing Peptide Receptor Antagonist, in GIST Patients

Biomedicines

2022/11/11

Molecular Characteristics of Radon Associated Lung Cancer Highlights MET Alterations

Cancers

2022/10/19

Claudia Manzl
Claudia Manzl

H-Index: 19

Nrf2 in the Field of Dentistry with Special Attention to NLRP3

2022/1/12

Claudia Manzl
Claudia Manzl

H-Index: 19

Patients with double/triple copy number gains on C-MYC, BCL2, and/or BCL6 treated with standard chemotherapy have a similarly poor prognosis than those with high-grade B cell …

Annals of Hematology

2020/9

Claudia Manzl
Claudia Manzl

H-Index: 19

Development of bivalent triarylalkene-and cyclofenil-derived dual estrogen receptor antagonists and downregulators

European Journal of Medicinal Chemistry

2020/4/15

Alexandra Knox
Alexandra Knox

H-Index: 3

Claudia Manzl
Claudia Manzl

H-Index: 19

See List of Professors in Claudia Manzl University(Medizinische Universität Innsbruck)